How many clinical trials are tracked of icotinib?

2 trials are tracked, 0 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Urology Dermatology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

icotinib

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of icotinib

2 trials tracked of icotinib: 1 in phase 3 or 4.

2Trials tracked

1Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 3 1 Phase 2 1

Phase 3 Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients Completed
Phase 2 Icotinib for Completed Resected IB NSCLC With EGFR Mutation Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.